CLINICAL_TRIALS
trial_result
· 2014-11-18
Clinical Trial Update: Neutrophilic Asthma Study With Navarixin (MK-7123, SCH 527123) (MK-7123-017)(COMPLETED) [Phase 2]
Summary
Phase 2 clinical trial update for neutrophilic asthma evaluating navarixin (MK-7123).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Neutrophilic Asthma | Phase 2 | Status: COMPLETED | Results posted: 2014-11-18